SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.
Oncotarget
; 9(11): 9608-9617, 2018 Feb 09.
Article
in En
| MEDLINE
| ID: mdl-29515757
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncotarget
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United States